Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

Clinical trial NCT06992583 · RECRUITING

Trial details

NCT number: NCT06992583
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Lung Cancer

Start date: 2025-05-08
Primary completion: 2028-02-29
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.